US Patent 8629157 Pyrrolidine compounds which modulate the CB2 receptor
Patent 8629157 was granted and assigned to Boehringer Ingelheim on January, 2014 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 15, 2009
Date of Patent
January 14, 2014
Patent Application Number
13141105
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8629157 Pyrrolidine compounds which modulate the CB2 receptor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
